The total pharmaceutical market in Türkiye has experienced several fluctuations since 2013, with notable declines in 2015, 2020, and 2022. Specifically, there was a significant decrease in 2020 (-15.08%) following a substantial increase in 2019 (+15.48%). More recently, the market value showed a modest recovery in 2023 with a 2.95% rise. As of 2023, the market stood at 31.4 units of generics in value. The Compounded Annual Growth Rate (CAGR) over the past five years was 0.26%, indicating a relatively stagnant market with slight growth.
Looking ahead to the forecasted period from 2024 to 2028, the market is expected to exhibit a mild decreasing trend, with a forecasted CAGR of -0.13%. This suggests a stable but slightly contracting pharmaceutical market in Türkiye. Factors influencing this trend will likely include regulatory changes, healthcare policies, and economic stability.
Future trends to watch for include the impact of technological advancements on pharmaceutical manufacturing, the uptake of biosimilars, policy shifts towards more stringent healthcare regulations, and potential market consolidation. Additionally, monitoring global supply chain dynamics and local economic conditions will be crucial for understanding long-term market movements.
